Cannabis Science Inc (OTCMKTS:CBIS) said it entered into a one-year deal with industry veteran Derwin A. Wallace to offer financial and investor relations services. The veteran will focus on creating and expanding the financial communications with both the institutional and retail investment groups. In addition, he will take care of the company’s coverage from research analysts carried through a detailed financial and investor relations plan.
Mr. Raymond C. Dabney, the CEO said the new agreement with industry veteran reflects Cannabis Science’s commitment to its shareholders to add shareholder value by putting $5 million to $25 million of funds. The company intends to generate adequate capital to move forward its strategic plans and take its extensive product line to the next level. The medical cannabis industry is witnessing significant change. It is no longer an ignored market.
With such a rapid change, there is a dire need for an expert to handle the necessary financial communications with the investors and analysts. It will make the participants to make a rapid and educated decision. The recent appointment is a step taken towards the completion of defined objectives. Mr. Wallace is an experienced person and has required expertise to help investors and analysts know the developments in a professional and transparent manner.
Prior to the joining agreement with Cannabis Science Inc (OTCMKTS:CBIS), Wallace has over fifteen years of investor relations experience at various reputed firms. As an investor relations expert, he possesses extensive experience communicating with retail investors, research analysts and institutional investors, including those participants inclined towards the growing medical cannabis industry. In 2014, he brought his experience to the cannabis industry and helped in the formation of the Cannabis Investor Conference. He also formed the Cannabis Investor Webcast. He is an MBA with specialization in Finance pursued from Keller Graduate School of Management.